PSMA-negative prostate cancer and the continued value of choline-PET/CT

被引：16
|
作者：
Alberts, Ian [1 ]
Sachpekidis, Christos [1 ]
Fech, Viktor [1 ]
Rominger, Axel [1 ]
Afshar-Oromieh, Ali [1 ]
机构：
[1] Univ Bern, Univ Hosp Bern, Inselspital, Dept Nucl Med, Bern, Switzerland
来源：
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2020年 / 59卷 / 01期
关键词：
D O I：
10.1055/a-1044-1855
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：33 / 34
页数：2
相关论文
共 50 条
  • [21] FAP is a Potential Theranostic Target for PSMA-negative Castration Resistant Prostate Cancer
    Zuo, Chunlai
    Huang, RongRong
    Mona, Christine
    Lotan, Tamara
    True, Lawrence
    Morrissey, Colm
    Czernin, Johannes
    Calais, Jeremie
    Magyar, Clara
    Ye, Huihui
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 637 - 638
  • [22] Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease
    Khreish, Fadi
    Rosar, Florian
    Kratochwil, Clemens
    Giesel, Frederik Lars
    Haberkorn, Uwe
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (08) : 2040 - 2041
  • [23] Positive FAPI-PET/CT in a metastatic castration-resistant prostate cancer patient with PSMA-negative/FDG-positive disease
    Fadi Khreish
    Florian Rosar
    Clemens Kratochwil
    Frederik Lars Giesel
    Uwe Haberkorn
    Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2040 - 2041
  • [24] FAP is a Potential Theranostic Target for PSMA-negative Castration Resistant Prostate Cancer
    Zuo, Chunlai
    Huang, RongRong
    Mona, Christine
    Lotan, Tamara
    True, Lawrence
    Morrissey, Colm
    Czernin, Johannes
    Calais, Jeremie
    Magyar, Clara
    Ye, Huihui
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 637 - 638
  • [25] Relationship of choline kinase expression assessed by choline-PET and prostate cancer cell aggressive phenotype
    Bansal, Aditya
    Harris, Robert
    DeGrado, Timothy
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [26] The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
    B. J. Krause
    M. Souvatzoglou
    M. Tuncel
    K. Herrmann
    A. K. Buck
    C. Praus
    T. Schuster
    H. Geinitz
    U. Treiber
    M. Schwaiger
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 18 - 23
  • [27] Prognostic significance of a negative PSMA PET/CT in biochemical recurrence of prostate cancer
    Harsini, Sara
    Martineau, Patrick
    Plaha, Sonia
    Saprunoff, Heather
    Chen, Catherine
    Bishop, Julia
    Tyldesley, Scott
    Wilson, Don
    Benard, Francois
    CANCER IMAGING, 2024, 24 (01)
  • [28] The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
    Krause, B. J.
    Souvatzoglou, M.
    Tuncel, M.
    Herrmann, K.
    Buck, A. K.
    Praus, C.
    Schuster, T.
    Geinitz, H.
    Treiber, U.
    Schwaiger, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (01) : 18 - 23
  • [29] Identifying sites of recurrence with choline-PET–CT imaging
    Paolo Castellucci
    Stefano Fanti
    Nature Reviews Urology, 2015, 12 : 134 - 135
  • [30] Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis
    Treglia, Giorgio
    Mestre, Ricardo Pereira
    Ferrari, Matteo
    Bosetti, Davide G.
    Pascale, Mariarosa
    Oikonomou, Eleni
    De Dosso, Sara
    Jermini, Fernando
    Prior, John O.
    Roggero, Enrico
    Giovanella, Luca
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 9 (02): : 127 - 139
12345